Morgan Stanley Raises Insulet Corporation (NASDAQ:PODD) Target Price To $ 105.00

Morgan Stanley maintains Insulet Corporation (NASDAQ:PODD) at Equal-Weight rating, while revising the price target. The research firm raises target price to $ 105.00 up from previous mark of $ 96.00.

According to the previous trading day, closing price of PODD was $ 87.67, representing a 54.84 % increase from the 52 week low of $ 56.62 and a 19.5 % decrease over the 52 week high of $ 108.91.

Insulet Corporation has a market capital of $ 5.17 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.

Be the first to comment

Leave a Reply